Patient's Genes May Guide Antidepressant Use
MedicineNet.com - Some 30 percent to 40 percent of patients fail their first drug treatment for major depression. Experts say that, right now, it's not possible to predict with any degree of accuracy which drug will work best for each patient. Clinicians are pinning
Source: www.medicinenet.com
GOV OKS INSURANCE LAW FOR MENTALLY ILL
New York Post - The bill requires insurance companies to cover 30 inpatient and 20 outpatient days of treatment for mental illnesses. Companies must give full coverage for "biologically based" mental illnesses including major depression, schizophrenia, bipolar
Source: www.nypost.com
Novartis Strategic Healthcare Portfolio Drives Sustained Strong
MSN MoneyCentral - AGO178 (agomelatine) began Phase III trials in the US at the end of 2006 as a once-daily treatment for patients with major depression. AGO178, which was licensed from Servier and for which Novartis has the US rights, has shown efficacy comparable
Source: news.moneycentral.msn.com
Treatment-Resistant Depression: Diagnostic Strategies and Current
Medscape News - Patients had a diagnosis of major depression (nonpsychotic), baseline HAMD-17 rating ≥ 20 following a minimum of 6 weeks of treatment with an SSRI or SNRI treatment. Exclusion criteria included a DSM-IV rating for substance abuse within the past 3
Source: www.medscape.com
Postpartum Depression
HealthCentral.com - In addition to the usual symptoms of major depression, women suffering from postpartum depression feel that they are unable to on HealthCentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any
Source: www.healthcentral.com
Click here for more information about bipolar depression bipolar depression
<< Home